GlassScriptPhysician profile
Howard Michael Natter
NPI 1578529210
$12,456.67
in general payments reported to CMS, 2019-2025
62 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,879 · 2020: $1,457 · 2021: $2,161 · 2022: $2,326 · 2023: $2,115 · 2024: $1,353 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,368 · Consulting Fee: $150 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,368.40 |
| Consulting Fee | $150.00 |
| Education | $115.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $893.29 | 2019-2025 | Tysabri |
| Emd Serono, INC. | $890.30 | 2019-2024 | Mavenclad |
| Novartis Pharmaceuticals Corporation | $791.10 | 2019-2024 | |
| Ucb, INC. | $719.13 | 2019-2024 | Briviact, Rystiggo, Zilbrysq |
| Abbott Laboratories | $627.95 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $610.59 | 2019-2023 | Austedo |
| Alexion Pharmaceuticals, INC. | $507.04 | 2019-2024 | Ultomiris, Soliris |
| Abbvie INC. | $453.68 | 2021-2024 | |
| Jazz Pharmaceuticals INC. | $444.01 | 2019-2024 | |
| Genzyme Corporation | $424.53 | 2019-2023 | |
| Genentech USA, INC. | $371.77 | 2019-2024 | Ocrevus, Enspryng |
| Lilly USA, LLC | $355.78 | 2019-2024 | Amyvid, Emgality, Reyvow |
| Acadia Pharmaceuticals INC | $332.80 | 2019-2024 | Nuplazid |
| Medtronic USA, INC. | $324.29 | 2019 | |
| Argenx US, INC. | $302.32 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Natter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.